Diabetes 2030 by Institute of Alternative Futures

dimanche 3 juillet 2016

IAF has conducted a study to provide detailed diabetes prevalence and cost forecasts for each of the 50 states, including demographic breakdowns. The study was commissioned by the global diabetes care company Novo Nordisk to provide insights into how this growing epidemic could affect local economies.

To download the report : http://www.altfutures.org/projects/diabetes-2030/